Vaccine Adjuvants Market - Forecast(2024 - 2030)

Report Code: HCR 10303 Report Format: PDF + Excel

Vaccine Adjuvants Market Overview

Vaccine Adjuvants Market size is forecast to reach $1.67 billion by 2025, growing at a CAGR of 8.24% during the forecast period 2020-2025. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. Aluminum adjuvants are used in vaccines such as hepatitis A, hepatitis B, diphtheria and tetanus-containing vaccines. Protection via donated antibodies is short-lived, whereas protection via the tetanus shot lasts 10 years or more. Immunologic adjuvants are often used to modify or augment the effects of a vaccine by stimulating the immune system to respond to the vaccine more vigorously, and thus providing increased immunity to a particular disease. Immunostimulants and adjuvants can be administered before, with, or after vaccines to amplify the specific immune response generating elevations of circulating antibody titers and numbers of plaque-forming cells. Rapidly increasing incidences of various diseases among the masses, increasing demand for improved vaccine treatments, increasing R&D activities and investments, and government investments for providing vaccine dosage to the people are driving the market growth in recent years. In addition, urgent need for vaccine development of novel coronavirus (COVID-19) and major product launches of key players like Seppic and Seqirus are other factors driving the growth of the market.

Report Coverage

The report: “Vaccine Adjuvants Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Vaccine Adjuvants Market. 

By Product Type: Particulate Adjuvants, Adjuvant Emulsions, Pathogen components, Combination Adjuvants, Others
By Route of Administration: Intramuscular Route, Subcutaneous Route, Intranasal Route, Oral Route, Intradermal Route, Others
By Disease Type: Infectious Diseases, Cancer, Others
By Application: Commercial, Research Activity
By End Users: Humans, Animals
By Geography: North America, Europe, Asia-Pacific, Rest of the World (RoW)

Key Takeaways

  • North America dominated the Vaccine Adjuvants Market in the year 2019 owing to increasing demand for improved medical results from vaccines, widespread transmission of coronavirus, growing prevalence of infectious diseases and increasing government investments for improvements in healthcare sector. The Vaccine Adjuvants Market scope for different regions will be provided in the final report.
  • Growing prevalence of infectious and chronic diseases in the last decade, increasing investments in R&D activities of vaccine, demand for vaccine of novel coronavirus (COVID-19) and increasing government expenditure for vaccine awareness programs have helped in significant growth of Vaccine Adjuvants Market. 
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Vaccine Adjuvants Market report.
  • Higher costs of adjuvant vaccine products are anticipated to hamper the market growth of the Vaccine Adjuvants Industry.

Vaccine Adjuvants Market Segment Analysis - By Product Type

Particulate Adjuvants held the largest share in the product type segment of Vaccine Adjuvants Market in 2019 and is estimated to grow at a CAGR of 7.5% during the forecast period 2020-2025. Particulate adjuvants have witnessed a surge in their market share, owing to their efficient treatments and several advantages. These include passive targeting to the antigen-presenting cells within the immune system, protection against adjuvant degradation, and ability for sustained antigen release. Aluminum salts are by far the most commonly used adjuvants in vaccines. There are only two aluminium salts which are used in clinically-approved vaccines, Alhydrogel and AdjuPhos, while the novel aluminium adjuvant used in Gardasil is a sulphated version of the latter. Increasing popularity of aluminium adjuvants is attributed to their quicker clinical approvals, better potential clinical services in its history and enhanced delivery of antigen to immune system. These factors have aided the market growth in the past few years on a large scale. Combination Adjuvants held the second largest share in 2019. With the help of combined strategies, the vaccine becomes capable of provoking an abundant and effective immunization to compete against antigens with minimal/no adverse effects on recipients. Pathogen Components is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to increasing R&D activities and newer product developments by market companies. 

Vaccine Adjuvants Market Segment Analysis -By Disease Type

Infectious Diseases hold the major share in the disease type segment of Vaccine Adjuvants Market in 2019. This growth is primarily driven by the large number of incidences every year. According to the World Health Organization (WHO), nearly 50,000 men, women and children are dying every day from infectious diseases. Diseases like malaria, dengue, influenza and hepatitis A, B & C are taking lives every year on a high rate. Secondary factors helping the growth include growing mass awareness about treatment by vaccines and presence of advanced pipeline products for vaccine adjuvants for treatment of infectious diseases. Cancer is forecast to grow at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to increasing cancer treatments across the world and major R&D activities by market players on cancer targeted drugs and therapies.

Vaccine Adjuvants Market Segment Analysis - By Geography 

North America dominates the geography segment of Vaccine Adjuvants Market with a share of more than 41.55% in 2019, followed by Europe. Rising incidence of serious epidemic diseases, demand for vaccine of novel COVID-19 amidst the widespread fatalities, high healthcare expenditure by the government and presence of key market players in this region have helped in the growth of Vaccine Adjuvants Market infrastructure. Europe held the second place in the geography segment share of the market, owing to presence of a well-developed healthcare infrastructure, growing prevalence of epidemics and presence of key market players in this region.

However, Asia-Pacific is estimated to grow at the fastest rate at a higher CAGR during the forecast period 2020-2025. This is owing to growing technological innovations in the healthcare sector, increasing awareness about vaccines, and increasing disposable income of the population.

Vaccine Adjuvants Market Drivers

Growing prevalence of infectious and chronic diseases

Infectious diseases are a leading cause of death worldwide, particularly in low income countries, especially in young children. Three infectious diseases were ranked in the top ten causes of death worldwide in 2016 by the World Health Organization. They are lower respiratory infections (3.0 million deaths), diarrheal diseases (1.4 million deaths), and tuberculosis (1.3 million deaths). Another infectious disease, malaria, accounts for a top cause of death in low income countries. On the other hand, chronic diseases has been rapidly increasing worldwide. It is estimated that by 2025, chronic diseases is set to contribute approximately to 60% of the 56.5 million total reported deaths in the world and approximately 46% of the global burden of disease. This has resulted in widespread demand for vaccines for proper treatment in less time. In recent months, there is a huge demand of Vaccine Adjuvants for COVID-19, which has further aided the market growth.

Increasing government expenditure for vaccine awareness programs

Ministries of Health in many countries are continually confronted with the challenge of protecting resources for essential programs from the vagaries of the domestic budgeting process and the volatility in external donor financing. Adequate and reliable health financing is one of several essential elements required to ensure continuity in service delivery, and to fund continuous increases in coverage, quality and access to health services. This is all the more important for disease specific preventive programs such as immunization. The health benefits of vaccination has helped people and government become aware and invest in development of vaccine products. This has fuelled the market growth by a large scale. R&D activities for finding vaccines for proper treatment of COVID-19 is projected to further drive the Infusion Market growth during the forecast period 2020-2025.

Vaccine Adjuvants Market Challenges

Higher costs of adjuvant vaccine products and development

Adjuvanted vaccines would be cost-effective at a $1 adjuvant cost (on top of the standard vaccine cost) when the adjuvant efficacy (in overcoming the difference between vaccine response in patients and healthy adults) is greater than or equal to 60% and economically dominant (provides both cost savings and health benefits) when the $1 adjuvant's efficacy is 100%. In most cases, this is out of the reach of the average patient. This is anticipated to hamper the market growth during the forecast period 2020-2025.

Vaccine Adjuvants Industry Outlook

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Vaccine Adjuvants Market. In 2019, Vaccine Adjuvants Market share is consolidated by the top players present in the market. Vaccine Adjuvants Market top 10 companies are Brenntag Biosector A/S, Seppic, Seqirus, Agenus, Inc., Novavax, Inc., Invivogen, SPI Pharma, Inc., Avanti Polar Lipids, Inc., MVP Laboratories, Inc. and OZ Biosciences among others.

Acquisitions/Product Launches

  • In April 2020, Seppic announced the launch of its new product, Montanide™ ISA 78 VG. Montanide™ ISA 78 VG is an innovative alternative to Montanide™ ISA 71 VG and Montanide™ ISA 71R VG. Designed for water-in-oil emulsions, this novel adjuvant is particularly stable and powerful.
  • In February 2020, Seqirus announced the U.S. FDA approval of its first-ever adjuvanted, cell-based pandemic influenza A (H5N1) Vaccine.
  • In April 2019, Agenus announced that the first patient was dosed in the clinical trial of its next-generation anti-CTLA-4 antibody (AGEN1181). AGEN1181, a novel 'Fc engineered' antibody with potential for enhanced anti-tumor functions, is specifically designed to boost cancer killing immune cells and deplete cells that block the activity of these cancer killing cells.

For more Lifesciences and Healthcare related reports, please click here
1. Vaccine Adjuvants Market Overview
    1.1 Definitions and Scope
2. Vaccine Adjuvants Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Disease Type 
    2.4 Key trends by Geography
3. Vaccine Adjuvants Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Vaccine Adjuvants Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Vaccine Adjuvants Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Vaccine Adjuvants Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Vaccine Adjuvants Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Vaccine Adjuvants Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Particulate Adjuvants
    8.2 Adjuvant Emulsions
    8.3 Pathogen Components
    8.4 Combination Adjuvants
    8.5 Others
9. Vaccine Adjuvants Market – By Route of Administration (Market Size –$Million/$Billion)
    9.1 Intramuscular Route
    9.2 Subcutaneous Route
    9.3 Intranasal Route
    9.4 Oral Route
    9.5 Intradermal Route
    9.6 Others
10. Vaccine Adjuvants Market – By Disease Type (Market Size –$Million/$Billion)
    10.1 Infectious Diseases
    10.2 Cancer
    10.3 Others
11. Vaccine Adjuvants Market – By Application Type (Market Size –$Million/$Billion)
    11.1 Research Activity
    11.2 Commercial
12. Vaccine Adjuvants Market – By End User (Market Size –$Million/$Billion)
    12.1 Human Beings
    12.2 Animals
13. Vaccine Adjuvants Market – By Geography (Market Size –$Million/$Billion)
    13.1 North America
        13.1.1 U.S.
        13.1.2 Canada
        13.1.3 Mexico
    13.2 Europe
        13.2.1 U.K.
        13.2.2 Germany
        13.2.3 France
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Rest of Europe
    13.3 Asia-Pacific
        13.3.1 China
        13.3.2 India
        13.3.3 Japan
        13.3.4 South Korea
        13.3.5 Australia & New Zealand
        13.3.6 Rest of Asia-Pacific
    13.4 Rest of the World
        13.4.1 Middle East
        13.4.2 Africa
        13.4.3 South America
14. Vaccine Adjuvants Market - Entropy
15. Vaccine Adjuvants Market – Industry/Segment Competition Landscape   (Premium) 
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
        15.1.4 Best Practices for Companies
16. Vaccine Adjuvants Market – Key Company List by Country Premium (Premium)
17. Vaccine Adjuvants Market Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Vaccine Adjuvants Market, By Product Market 2023-2030 ($M)
1.1 Pathogen Components Market 2023-2030 ($M) - Global Industry Research
1.2 Particulate Adjuvants Market 2023-2030 ($M) - Global Industry Research
1.3 Combination Adjuvants Market 2023-2030 ($M) - Global Industry Research
1.4 Adjuvant Emulsions Market 2023-2030 ($M) - Global Industry Research
1.5 Saponin Market 2023-2030 ($M) - Global Industry Research
2.Global Vaccine Adjuvants Market, By Disease Type Market 2023-2030 ($M)
2.1 Cancer Market 2023-2030 ($M) - Global Industry Research
2.2 Infectious Diseases Market 2023-2030 ($M) - Global Industry Research
3.Global Vaccine Adjuvants Market, By Type Market 2023-2030 ($M)
3.1 Virus-like Particles Market 2023-2030 ($M) - Global Industry Research
3.2 Tensoactive Adjuvants Market 2023-2030 ($M) - Global Industry Research
3.3 Organic Adjuvants Market 2023-2030 ($M) - Global Industry Research
3.4 Mineral Salt based Adjuvants Market 2023-2030 ($M) - Global Industry Research
3.5 Liposomes Market 2023-2030 ($M) - Global Industry Research
3.6 Emulsions Market 2023-2030 ($M) - Global Industry Research
3.7 Carbohydrates Adjuvants Market 2023-2030 ($M) - Global Industry Research
3.8 Bacteria-derived Adjuvants Market 2023-2030 ($M) - Global Industry Research
4.Global Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 ($M)
4.1 Vehicle Adjuvants Market 2023-2030 ($M) - Global Industry Research
4.2 Carriers Market 2023-2030 ($M) - Global Industry Research
4.3 Active Immunostimulants Market 2023-2030 ($M) - Global Industry Research
5.Global Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 ($M)
5.1 Subcutaneous Route Market 2023-2030 ($M) - Global Industry Research
5.2 Oral Route Market 2023-2030 ($M) - Global Industry Research
5.3 Intranasal Route Market 2023-2030 ($M) - Global Industry Research
5.4 Intramuscular Route Market 2023-2030 ($M) - Global Industry Research
5.5 Intradermal Route Market 2023-2030 ($M) - Global Industry Research
6.Global Vaccine Adjuvants Market, By End User Market 2023-2030 ($M)
6.1 Research Institutes Market 2023-2030 ($M) - Global Industry Research
6.2 Pharmaceutical Companies Market 2023-2030 ($M) - Global Industry Research
6.3 Contract Manufacturing Organization Market 2023-2030 ($M) - Global Industry Research
6.4 Commercial Market 2023-2030 ($M) - Global Industry Research
6.5 Pediatric Market 2023-2030 ($M) - Global Industry Research
6.6 Adults Market 2023-2030 ($M) - Global Industry Research
7.Global Company Profiling Market 2023-2030 ($M)
7.1 Viscogel AB Market 2023-2030 ($M) - Global Industry Research
7.2 Vaxliant Market 2023-2030 ($M) - Global Industry Research
7.3 Vaxine Pty Ltd. Market 2023-2030 ($M) - Global Industry Research
7.4 Sigma Aldrich Market 2023-2030 ($M) - Global Industry Research
7.5 Sergeant Adjuvants Market 2023-2030 ($M) - Global Industry Research
7.6 OZ Biosciences Market 2023-2030 ($M) - Global Industry Research
7.7 Novavax, Inc. Market 2023-2030 ($M) - Global Industry Research
7.8 Novartis/CSL Market 2023-2030 ($M) - Global Industry Research
7.9 MVP Laboratories, Inc. Market 2023-2030 ($M) - Global Industry Research
7.10 Kineta, Inc. Market 2023-2030 ($M) - Global Industry Research
7.11 Invivogen Market 2023-2030 ($M) - Global Industry Research
7.12 GSK Market 2023-2030 ($M) - Global Industry Research
7.13 CureVac AG Market 2023-2030 ($M) - Global Industry Research
7.14 CSL Limited Market 2023-2030 ($M) - Global Industry Research
7.15 Avanti Polar Lipids Market 2023-2030 ($M) - Global Industry Research
7.16 Aphios Corp. Market 2023-2030 ($M) - Global Industry Research
7.17 Agenus, Inc. Market 2023-2030 ($M) - Global Industry Research
7.18 Adjuvatis Market 2023-2030 ($M) - Global Industry Research
7.19 Adjuvance Technologies, Inc Market 2023-2030 ($M) - Global Industry Research
8.Global Vaccine Adjuvants Market, By Product Market 2023-2030 (Volume/Units)
8.1 Pathogen Components Market 2023-2030 (Volume/Units) - Global Industry Research
8.2 Particulate Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
8.3 Combination Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
8.4 Adjuvant Emulsions Market 2023-2030 (Volume/Units) - Global Industry Research
8.5 Saponin Market 2023-2030 (Volume/Units) - Global Industry Research
9.Global Vaccine Adjuvants Market, By Disease Type Market 2023-2030 (Volume/Units)
9.1 Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
9.2 Infectious Diseases Market 2023-2030 (Volume/Units) - Global Industry Research
10.Global Vaccine Adjuvants Market, By Type Market 2023-2030 (Volume/Units)
10.1 Virus-like Particles Market 2023-2030 (Volume/Units) - Global Industry Research
10.2 Tensoactive Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
10.3 Organic Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
10.4 Mineral Salt based Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
10.5 Liposomes Market 2023-2030 (Volume/Units) - Global Industry Research
10.6 Emulsions Market 2023-2030 (Volume/Units) - Global Industry Research
10.7 Carbohydrates Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
10.8 Bacteria-derived Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
11.Global Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 (Volume/Units)
11.1 Vehicle Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
11.2 Carriers Market 2023-2030 (Volume/Units) - Global Industry Research
11.3 Active Immunostimulants Market 2023-2030 (Volume/Units) - Global Industry Research
12.Global Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 (Volume/Units)
12.1 Subcutaneous Route Market 2023-2030 (Volume/Units) - Global Industry Research
12.2 Oral Route Market 2023-2030 (Volume/Units) - Global Industry Research
12.3 Intranasal Route Market 2023-2030 (Volume/Units) - Global Industry Research
12.4 Intramuscular Route Market 2023-2030 (Volume/Units) - Global Industry Research
12.5 Intradermal Route Market 2023-2030 (Volume/Units) - Global Industry Research
13.Global Vaccine Adjuvants Market, By End User Market 2023-2030 (Volume/Units)
13.1 Research Institutes Market 2023-2030 (Volume/Units) - Global Industry Research
13.2 Pharmaceutical Companies Market 2023-2030 (Volume/Units) - Global Industry Research
13.3 Contract Manufacturing Organization Market 2023-2030 (Volume/Units) - Global Industry Research
13.4 Commercial Market 2023-2030 (Volume/Units) - Global Industry Research
13.5 Pediatric Market 2023-2030 (Volume/Units) - Global Industry Research
13.6 Adults Market 2023-2030 (Volume/Units) - Global Industry Research
14.Global Company Profiling Market 2023-2030 (Volume/Units)
14.1 Viscogel AB Market 2023-2030 (Volume/Units) - Global Industry Research
14.2 Vaxliant Market 2023-2030 (Volume/Units) - Global Industry Research
14.3 Vaxine Pty Ltd. Market 2023-2030 (Volume/Units) - Global Industry Research
14.4 Sigma Aldrich Market 2023-2030 (Volume/Units) - Global Industry Research
14.5 Sergeant Adjuvants Market 2023-2030 (Volume/Units) - Global Industry Research
14.6 OZ Biosciences Market 2023-2030 (Volume/Units) - Global Industry Research
14.7 Novavax, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
14.8 Novartis/CSL Market 2023-2030 (Volume/Units) - Global Industry Research
14.9 MVP Laboratories, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
14.10 Kineta, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
14.11 Invivogen Market 2023-2030 (Volume/Units) - Global Industry Research
14.12 GSK Market 2023-2030 (Volume/Units) - Global Industry Research
14.13 CureVac AG Market 2023-2030 (Volume/Units) - Global Industry Research
14.14 CSL Limited Market 2023-2030 (Volume/Units) - Global Industry Research
14.15 Avanti Polar Lipids Market 2023-2030 (Volume/Units) - Global Industry Research
14.16 Aphios Corp. Market 2023-2030 (Volume/Units) - Global Industry Research
14.17 Agenus, Inc. Market 2023-2030 (Volume/Units) - Global Industry Research
14.18 Adjuvatis Market 2023-2030 (Volume/Units) - Global Industry Research
14.19 Adjuvance Technologies, Inc Market 2023-2030 (Volume/Units) - Global Industry Research
15.North America Vaccine Adjuvants Market, By Product Market 2023-2030 ($M)
15.1 Pathogen Components Market 2023-2030 ($M) - Regional Industry Research
15.2 Particulate Adjuvants Market 2023-2030 ($M) - Regional Industry Research
15.3 Combination Adjuvants Market 2023-2030 ($M) - Regional Industry Research
15.4 Adjuvant Emulsions Market 2023-2030 ($M) - Regional Industry Research
15.5 Saponin Market 2023-2030 ($M) - Regional Industry Research
16.North America Vaccine Adjuvants Market, By Disease Type Market 2023-2030 ($M)
16.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
16.2 Infectious Diseases Market 2023-2030 ($M) - Regional Industry Research
17.North America Vaccine Adjuvants Market, By Type Market 2023-2030 ($M)
17.1 Virus-like Particles Market 2023-2030 ($M) - Regional Industry Research
17.2 Tensoactive Adjuvants Market 2023-2030 ($M) - Regional Industry Research
17.3 Organic Adjuvants Market 2023-2030 ($M) - Regional Industry Research
17.4 Mineral Salt based Adjuvants Market 2023-2030 ($M) - Regional Industry Research
17.5 Liposomes Market 2023-2030 ($M) - Regional Industry Research
17.6 Emulsions Market 2023-2030 ($M) - Regional Industry Research
17.7 Carbohydrates Adjuvants Market 2023-2030 ($M) - Regional Industry Research
17.8 Bacteria-derived Adjuvants Market 2023-2030 ($M) - Regional Industry Research
18.North America Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 ($M)
18.1 Vehicle Adjuvants Market 2023-2030 ($M) - Regional Industry Research
18.2 Carriers Market 2023-2030 ($M) - Regional Industry Research
18.3 Active Immunostimulants Market 2023-2030 ($M) - Regional Industry Research
19.North America Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 ($M)
19.1 Subcutaneous Route Market 2023-2030 ($M) - Regional Industry Research
19.2 Oral Route Market 2023-2030 ($M) - Regional Industry Research
19.3 Intranasal Route Market 2023-2030 ($M) - Regional Industry Research
19.4 Intramuscular Route Market 2023-2030 ($M) - Regional Industry Research
19.5 Intradermal Route Market 2023-2030 ($M) - Regional Industry Research
20.North America Vaccine Adjuvants Market, By End User Market 2023-2030 ($M)
20.1 Research Institutes Market 2023-2030 ($M) - Regional Industry Research
20.2 Pharmaceutical Companies Market 2023-2030 ($M) - Regional Industry Research
20.3 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
20.4 Commercial Market 2023-2030 ($M) - Regional Industry Research
20.5 Pediatric Market 2023-2030 ($M) - Regional Industry Research
20.6 Adults Market 2023-2030 ($M) - Regional Industry Research
21.North America Company Profiling Market 2023-2030 ($M)
21.1 Viscogel AB Market 2023-2030 ($M) - Regional Industry Research
21.2 Vaxliant Market 2023-2030 ($M) - Regional Industry Research
21.3 Vaxine Pty Ltd. Market 2023-2030 ($M) - Regional Industry Research
21.4 Sigma Aldrich Market 2023-2030 ($M) - Regional Industry Research
21.5 Sergeant Adjuvants Market 2023-2030 ($M) - Regional Industry Research
21.6 OZ Biosciences Market 2023-2030 ($M) - Regional Industry Research
21.7 Novavax, Inc. Market 2023-2030 ($M) - Regional Industry Research
21.8 Novartis/CSL Market 2023-2030 ($M) - Regional Industry Research
21.9 MVP Laboratories, Inc. Market 2023-2030 ($M) - Regional Industry Research
21.10 Kineta, Inc. Market 2023-2030 ($M) - Regional Industry Research
21.11 Invivogen Market 2023-2030 ($M) - Regional Industry Research
21.12 GSK Market 2023-2030 ($M) - Regional Industry Research
21.13 CureVac AG Market 2023-2030 ($M) - Regional Industry Research
21.14 CSL Limited Market 2023-2030 ($M) - Regional Industry Research
21.15 Avanti Polar Lipids Market 2023-2030 ($M) - Regional Industry Research
21.16 Aphios Corp. Market 2023-2030 ($M) - Regional Industry Research
21.17 Agenus, Inc. Market 2023-2030 ($M) - Regional Industry Research
21.18 Adjuvatis Market 2023-2030 ($M) - Regional Industry Research
21.19 Adjuvance Technologies, Inc Market 2023-2030 ($M) - Regional Industry Research
22.South America Vaccine Adjuvants Market, By Product Market 2023-2030 ($M)
22.1 Pathogen Components Market 2023-2030 ($M) - Regional Industry Research
22.2 Particulate Adjuvants Market 2023-2030 ($M) - Regional Industry Research
22.3 Combination Adjuvants Market 2023-2030 ($M) - Regional Industry Research
22.4 Adjuvant Emulsions Market 2023-2030 ($M) - Regional Industry Research
22.5 Saponin Market 2023-2030 ($M) - Regional Industry Research
23.South America Vaccine Adjuvants Market, By Disease Type Market 2023-2030 ($M)
23.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
23.2 Infectious Diseases Market 2023-2030 ($M) - Regional Industry Research
24.South America Vaccine Adjuvants Market, By Type Market 2023-2030 ($M)
24.1 Virus-like Particles Market 2023-2030 ($M) - Regional Industry Research
24.2 Tensoactive Adjuvants Market 2023-2030 ($M) - Regional Industry Research
24.3 Organic Adjuvants Market 2023-2030 ($M) - Regional Industry Research
24.4 Mineral Salt based Adjuvants Market 2023-2030 ($M) - Regional Industry Research
24.5 Liposomes Market 2023-2030 ($M) - Regional Industry Research
24.6 Emulsions Market 2023-2030 ($M) - Regional Industry Research
24.7 Carbohydrates Adjuvants Market 2023-2030 ($M) - Regional Industry Research
24.8 Bacteria-derived Adjuvants Market 2023-2030 ($M) - Regional Industry Research
25.South America Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 ($M)
25.1 Vehicle Adjuvants Market 2023-2030 ($M) - Regional Industry Research
25.2 Carriers Market 2023-2030 ($M) - Regional Industry Research
25.3 Active Immunostimulants Market 2023-2030 ($M) - Regional Industry Research
26.South America Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 ($M)
26.1 Subcutaneous Route Market 2023-2030 ($M) - Regional Industry Research
26.2 Oral Route Market 2023-2030 ($M) - Regional Industry Research
26.3 Intranasal Route Market 2023-2030 ($M) - Regional Industry Research
26.4 Intramuscular Route Market 2023-2030 ($M) - Regional Industry Research
26.5 Intradermal Route Market 2023-2030 ($M) - Regional Industry Research
27.South America Vaccine Adjuvants Market, By End User Market 2023-2030 ($M)
27.1 Research Institutes Market 2023-2030 ($M) - Regional Industry Research
27.2 Pharmaceutical Companies Market 2023-2030 ($M) - Regional Industry Research
27.3 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
27.4 Commercial Market 2023-2030 ($M) - Regional Industry Research
27.5 Pediatric Market 2023-2030 ($M) - Regional Industry Research
27.6 Adults Market 2023-2030 ($M) - Regional Industry Research
28.South America Company Profiling Market 2023-2030 ($M)
28.1 Viscogel AB Market 2023-2030 ($M) - Regional Industry Research
28.2 Vaxliant Market 2023-2030 ($M) - Regional Industry Research
28.3 Vaxine Pty Ltd. Market 2023-2030 ($M) - Regional Industry Research
28.4 Sigma Aldrich Market 2023-2030 ($M) - Regional Industry Research
28.5 Sergeant Adjuvants Market 2023-2030 ($M) - Regional Industry Research
28.6 OZ Biosciences Market 2023-2030 ($M) - Regional Industry Research
28.7 Novavax, Inc. Market 2023-2030 ($M) - Regional Industry Research
28.8 Novartis/CSL Market 2023-2030 ($M) - Regional Industry Research
28.9 MVP Laboratories, Inc. Market 2023-2030 ($M) - Regional Industry Research
28.10 Kineta, Inc. Market 2023-2030 ($M) - Regional Industry Research
28.11 Invivogen Market 2023-2030 ($M) - Regional Industry Research
28.12 GSK Market 2023-2030 ($M) - Regional Industry Research
28.13 CureVac AG Market 2023-2030 ($M) - Regional Industry Research
28.14 CSL Limited Market 2023-2030 ($M) - Regional Industry Research
28.15 Avanti Polar Lipids Market 2023-2030 ($M) - Regional Industry Research
28.16 Aphios Corp. Market 2023-2030 ($M) - Regional Industry Research
28.17 Agenus, Inc. Market 2023-2030 ($M) - Regional Industry Research
28.18 Adjuvatis Market 2023-2030 ($M) - Regional Industry Research
28.19 Adjuvance Technologies, Inc Market 2023-2030 ($M) - Regional Industry Research
29.Europe Vaccine Adjuvants Market, By Product Market 2023-2030 ($M)
29.1 Pathogen Components Market 2023-2030 ($M) - Regional Industry Research
29.2 Particulate Adjuvants Market 2023-2030 ($M) - Regional Industry Research
29.3 Combination Adjuvants Market 2023-2030 ($M) - Regional Industry Research
29.4 Adjuvant Emulsions Market 2023-2030 ($M) - Regional Industry Research
29.5 Saponin Market 2023-2030 ($M) - Regional Industry Research
30.Europe Vaccine Adjuvants Market, By Disease Type Market 2023-2030 ($M)
30.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
30.2 Infectious Diseases Market 2023-2030 ($M) - Regional Industry Research
31.Europe Vaccine Adjuvants Market, By Type Market 2023-2030 ($M)
31.1 Virus-like Particles Market 2023-2030 ($M) - Regional Industry Research
31.2 Tensoactive Adjuvants Market 2023-2030 ($M) - Regional Industry Research
31.3 Organic Adjuvants Market 2023-2030 ($M) - Regional Industry Research
31.4 Mineral Salt based Adjuvants Market 2023-2030 ($M) - Regional Industry Research
31.5 Liposomes Market 2023-2030 ($M) - Regional Industry Research
31.6 Emulsions Market 2023-2030 ($M) - Regional Industry Research
31.7 Carbohydrates Adjuvants Market 2023-2030 ($M) - Regional Industry Research
31.8 Bacteria-derived Adjuvants Market 2023-2030 ($M) - Regional Industry Research
32.Europe Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 ($M)
32.1 Vehicle Adjuvants Market 2023-2030 ($M) - Regional Industry Research
32.2 Carriers Market 2023-2030 ($M) - Regional Industry Research
32.3 Active Immunostimulants Market 2023-2030 ($M) - Regional Industry Research
33.Europe Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 ($M)
33.1 Subcutaneous Route Market 2023-2030 ($M) - Regional Industry Research
33.2 Oral Route Market 2023-2030 ($M) - Regional Industry Research
33.3 Intranasal Route Market 2023-2030 ($M) - Regional Industry Research
33.4 Intramuscular Route Market 2023-2030 ($M) - Regional Industry Research
33.5 Intradermal Route Market 2023-2030 ($M) - Regional Industry Research
34.Europe Vaccine Adjuvants Market, By End User Market 2023-2030 ($M)
34.1 Research Institutes Market 2023-2030 ($M) - Regional Industry Research
34.2 Pharmaceutical Companies Market 2023-2030 ($M) - Regional Industry Research
34.3 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
34.4 Commercial Market 2023-2030 ($M) - Regional Industry Research
34.5 Pediatric Market 2023-2030 ($M) - Regional Industry Research
34.6 Adults Market 2023-2030 ($M) - Regional Industry Research
35.Europe Company Profiling Market 2023-2030 ($M)
35.1 Viscogel AB Market 2023-2030 ($M) - Regional Industry Research
35.2 Vaxliant Market 2023-2030 ($M) - Regional Industry Research
35.3 Vaxine Pty Ltd. Market 2023-2030 ($M) - Regional Industry Research
35.4 Sigma Aldrich Market 2023-2030 ($M) - Regional Industry Research
35.5 Sergeant Adjuvants Market 2023-2030 ($M) - Regional Industry Research
35.6 OZ Biosciences Market 2023-2030 ($M) - Regional Industry Research
35.7 Novavax, Inc. Market 2023-2030 ($M) - Regional Industry Research
35.8 Novartis/CSL Market 2023-2030 ($M) - Regional Industry Research
35.9 MVP Laboratories, Inc. Market 2023-2030 ($M) - Regional Industry Research
35.10 Kineta, Inc. Market 2023-2030 ($M) - Regional Industry Research
35.11 Invivogen Market 2023-2030 ($M) - Regional Industry Research
35.12 GSK Market 2023-2030 ($M) - Regional Industry Research
35.13 CureVac AG Market 2023-2030 ($M) - Regional Industry Research
35.14 CSL Limited Market 2023-2030 ($M) - Regional Industry Research
35.15 Avanti Polar Lipids Market 2023-2030 ($M) - Regional Industry Research
35.16 Aphios Corp. Market 2023-2030 ($M) - Regional Industry Research
35.17 Agenus, Inc. Market 2023-2030 ($M) - Regional Industry Research
35.18 Adjuvatis Market 2023-2030 ($M) - Regional Industry Research
35.19 Adjuvance Technologies, Inc Market 2023-2030 ($M) - Regional Industry Research
36.APAC Vaccine Adjuvants Market, By Product Market 2023-2030 ($M)
36.1 Pathogen Components Market 2023-2030 ($M) - Regional Industry Research
36.2 Particulate Adjuvants Market 2023-2030 ($M) - Regional Industry Research
36.3 Combination Adjuvants Market 2023-2030 ($M) - Regional Industry Research
36.4 Adjuvant Emulsions Market 2023-2030 ($M) - Regional Industry Research
36.5 Saponin Market 2023-2030 ($M) - Regional Industry Research
37.APAC Vaccine Adjuvants Market, By Disease Type Market 2023-2030 ($M)
37.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
37.2 Infectious Diseases Market 2023-2030 ($M) - Regional Industry Research
38.APAC Vaccine Adjuvants Market, By Type Market 2023-2030 ($M)
38.1 Virus-like Particles Market 2023-2030 ($M) - Regional Industry Research
38.2 Tensoactive Adjuvants Market 2023-2030 ($M) - Regional Industry Research
38.3 Organic Adjuvants Market 2023-2030 ($M) - Regional Industry Research
38.4 Mineral Salt based Adjuvants Market 2023-2030 ($M) - Regional Industry Research
38.5 Liposomes Market 2023-2030 ($M) - Regional Industry Research
38.6 Emulsions Market 2023-2030 ($M) - Regional Industry Research
38.7 Carbohydrates Adjuvants Market 2023-2030 ($M) - Regional Industry Research
38.8 Bacteria-derived Adjuvants Market 2023-2030 ($M) - Regional Industry Research
39.APAC Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 ($M)
39.1 Vehicle Adjuvants Market 2023-2030 ($M) - Regional Industry Research
39.2 Carriers Market 2023-2030 ($M) - Regional Industry Research
39.3 Active Immunostimulants Market 2023-2030 ($M) - Regional Industry Research
40.APAC Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 ($M)
40.1 Subcutaneous Route Market 2023-2030 ($M) - Regional Industry Research
40.2 Oral Route Market 2023-2030 ($M) - Regional Industry Research
40.3 Intranasal Route Market 2023-2030 ($M) - Regional Industry Research
40.4 Intramuscular Route Market 2023-2030 ($M) - Regional Industry Research
40.5 Intradermal Route Market 2023-2030 ($M) - Regional Industry Research
41.APAC Vaccine Adjuvants Market, By End User Market 2023-2030 ($M)
41.1 Research Institutes Market 2023-2030 ($M) - Regional Industry Research
41.2 Pharmaceutical Companies Market 2023-2030 ($M) - Regional Industry Research
41.3 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
41.4 Commercial Market 2023-2030 ($M) - Regional Industry Research
41.5 Pediatric Market 2023-2030 ($M) - Regional Industry Research
41.6 Adults Market 2023-2030 ($M) - Regional Industry Research
42.APAC Company Profiling Market 2023-2030 ($M)
42.1 Viscogel AB Market 2023-2030 ($M) - Regional Industry Research
42.2 Vaxliant Market 2023-2030 ($M) - Regional Industry Research
42.3 Vaxine Pty Ltd. Market 2023-2030 ($M) - Regional Industry Research
42.4 Sigma Aldrich Market 2023-2030 ($M) - Regional Industry Research
42.5 Sergeant Adjuvants Market 2023-2030 ($M) - Regional Industry Research
42.6 OZ Biosciences Market 2023-2030 ($M) - Regional Industry Research
42.7 Novavax, Inc. Market 2023-2030 ($M) - Regional Industry Research
42.8 Novartis/CSL Market 2023-2030 ($M) - Regional Industry Research
42.9 MVP Laboratories, Inc. Market 2023-2030 ($M) - Regional Industry Research
42.10 Kineta, Inc. Market 2023-2030 ($M) - Regional Industry Research
42.11 Invivogen Market 2023-2030 ($M) - Regional Industry Research
42.12 GSK Market 2023-2030 ($M) - Regional Industry Research
42.13 CureVac AG Market 2023-2030 ($M) - Regional Industry Research
42.14 CSL Limited Market 2023-2030 ($M) - Regional Industry Research
42.15 Avanti Polar Lipids Market 2023-2030 ($M) - Regional Industry Research
42.16 Aphios Corp. Market 2023-2030 ($M) - Regional Industry Research
42.17 Agenus, Inc. Market 2023-2030 ($M) - Regional Industry Research
42.18 Adjuvatis Market 2023-2030 ($M) - Regional Industry Research
42.19 Adjuvance Technologies, Inc Market 2023-2030 ($M) - Regional Industry Research
43.MENA Vaccine Adjuvants Market, By Product Market 2023-2030 ($M)
43.1 Pathogen Components Market 2023-2030 ($M) - Regional Industry Research
43.2 Particulate Adjuvants Market 2023-2030 ($M) - Regional Industry Research
43.3 Combination Adjuvants Market 2023-2030 ($M) - Regional Industry Research
43.4 Adjuvant Emulsions Market 2023-2030 ($M) - Regional Industry Research
43.5 Saponin Market 2023-2030 ($M) - Regional Industry Research
44.MENA Vaccine Adjuvants Market, By Disease Type Market 2023-2030 ($M)
44.1 Cancer Market 2023-2030 ($M) - Regional Industry Research
44.2 Infectious Diseases Market 2023-2030 ($M) - Regional Industry Research
45.MENA Vaccine Adjuvants Market, By Type Market 2023-2030 ($M)
45.1 Virus-like Particles Market 2023-2030 ($M) - Regional Industry Research
45.2 Tensoactive Adjuvants Market 2023-2030 ($M) - Regional Industry Research
45.3 Organic Adjuvants Market 2023-2030 ($M) - Regional Industry Research
45.4 Mineral Salt based Adjuvants Market 2023-2030 ($M) - Regional Industry Research
45.5 Liposomes Market 2023-2030 ($M) - Regional Industry Research
45.6 Emulsions Market 2023-2030 ($M) - Regional Industry Research
45.7 Carbohydrates Adjuvants Market 2023-2030 ($M) - Regional Industry Research
45.8 Bacteria-derived Adjuvants Market 2023-2030 ($M) - Regional Industry Research
46.MENA Vaccine Adjuvants Market, By Mechanism of action Market 2023-2030 ($M)
46.1 Vehicle Adjuvants Market 2023-2030 ($M) - Regional Industry Research
46.2 Carriers Market 2023-2030 ($M) - Regional Industry Research
46.3 Active Immunostimulants Market 2023-2030 ($M) - Regional Industry Research
47.MENA Vaccine Adjuvants Market, By Route of Administration Market 2023-2030 ($M)
47.1 Subcutaneous Route Market 2023-2030 ($M) - Regional Industry Research
47.2 Oral Route Market 2023-2030 ($M) - Regional Industry Research
47.3 Intranasal Route Market 2023-2030 ($M) - Regional Industry Research
47.4 Intramuscular Route Market 2023-2030 ($M) - Regional Industry Research
47.5 Intradermal Route Market 2023-2030 ($M) - Regional Industry Research
48.MENA Vaccine Adjuvants Market, By End User Market 2023-2030 ($M)
48.1 Research Institutes Market 2023-2030 ($M) - Regional Industry Research
48.2 Pharmaceutical Companies Market 2023-2030 ($M) - Regional Industry Research
48.3 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
48.4 Commercial Market 2023-2030 ($M) - Regional Industry Research
48.5 Pediatric Market 2023-2030 ($M) - Regional Industry Research
48.6 Adults Market 2023-2030 ($M) - Regional Industry Research
49.MENA Company Profiling Market 2023-2030 ($M)
49.1 Viscogel AB Market 2023-2030 ($M) - Regional Industry Research
49.2 Vaxliant Market 2023-2030 ($M) - Regional Industry Research
49.3 Vaxine Pty Ltd. Market 2023-2030 ($M) - Regional Industry Research
49.4 Sigma Aldrich Market 2023-2030 ($M) - Regional Industry Research
49.5 Sergeant Adjuvants Market 2023-2030 ($M) - Regional Industry Research
49.6 OZ Biosciences Market 2023-2030 ($M) - Regional Industry Research
49.7 Novavax, Inc. Market 2023-2030 ($M) - Regional Industry Research
49.8 Novartis/CSL Market 2023-2030 ($M) - Regional Industry Research
49.9 MVP Laboratories, Inc. Market 2023-2030 ($M) - Regional Industry Research
49.10 Kineta, Inc. Market 2023-2030 ($M) - Regional Industry Research
49.11 Invivogen Market 2023-2030 ($M) - Regional Industry Research
49.12 GSK Market 2023-2030 ($M) - Regional Industry Research
49.13 CureVac AG Market 2023-2030 ($M) - Regional Industry Research
49.14 CSL Limited Market 2023-2030 ($M) - Regional Industry Research
49.15 Avanti Polar Lipids Market 2023-2030 ($M) - Regional Industry Research
49.16 Aphios Corp. Market 2023-2030 ($M) - Regional Industry Research
49.17 Agenus, Inc. Market 2023-2030 ($M) - Regional Industry Research
49.18 Adjuvatis Market 2023-2030 ($M) - Regional Industry Research
49.19 Adjuvance Technologies, Inc Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
2.Canada Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
3.Mexico Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
4.Brazil Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
5.Argentina Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
6.Peru Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
7.Colombia Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
8.Chile Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
9.Rest of South America Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
10.UK Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
11.Germany Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
12.France Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
13.Italy Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
14.Spain Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
15.Rest of Europe Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
16.China Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
17.India Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
18.Japan Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
19.South Korea Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
20.South Africa Vaccine Adjuvants Global Market Revenue, 2023-2030 ($M)
21.North America Vaccine Adjuvants Global By Application
22.South America Vaccine Adjuvants Global By Application
23.Europe Vaccine Adjuvants Global By Application
24.APAC Vaccine Adjuvants Global By Application
25.MENA Vaccine Adjuvants Global By Application